Insider · CIK 0001255743
James J Bochnowski
Files at JAGX (Jaguar Health, Inc.). First filing -, latest -.
In brief
James J Bochnowski files SEC Form 4 as director at JAGX (Jaguar Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James J Bochnowski has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Common Stock | +6,363 | $0.00 | $0 | 6,415 | Dec 15, 2025 |
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Stock Option (right to buy)derivative | +6,363 | $0.00 | $0 | 6,363 | Dec 15, 2025 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | DDisposition to issuer Convertible Promissory Notederivativeindirect: See footnote | -27,002 | $150,000.00 | $4.1B | 0 | Jun 26, 2025 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Convertible Promissory Notederivativeindirect: See footnote | +28,388 | $150,000.00 | $4.3B | 28,388 | Jun 26, 2025 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Warrant to Purchase Common Stockderivativeindirect: See footnote | +54,786 | - | - | 27,002 | Jun 26, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Convertible Promissory Notederivativeindirect: See Footnote | +27,002 | $150,000.00 | $4.1B | 27,002 | Apr 2, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivativeindirect: See Footnote | +27,002 | - | - | 27,002 | Apr 2, 2025 |
Questions about James J Bochnowski
Answered from the filings on this page, as of the latest one.
Is James J Bochnowski buying or selling?
James J Bochnowski has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James J Bochnowski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James J Bochnowski has 0.
Where does James J Bochnowski file Form 4?
James J Bochnowski has filed Form 4 at JAGX (Jaguar Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.